Robbins Farley LLC Bio N Tech Se Transaction History

Robbins Farley LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $111,949 - $160,587	877 New	877 $118,000
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $1.63 Million - $2.46 Million	-13,220 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $1.67 Million - $3.07 Million	13,220 New	13,220 $2.26 Million
Q4 2021 Feb 02, 2022	SELL	$216.64 - $362.52 $1.67 Million - $2.8 Million	-7,721 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $1.59 Million - $3.45 Million	7,721 New	7,721 $2.11 Million
Q2 2021 Aug 13, 2021	SELL	$113.32 - $241.49 $352,538 - $751,275	-3,111 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$85.73 - $119.5 $266,706 - $371,764	3,111 New	3,111 $630,000

356

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Robbins Farley LLC, based on Form 13F filings with the SEC.

Stay updated on Robbins Farley LLC with notifications on news.